Angiocrine Bioscience, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Angiocrine Bioscience, Inc. is a private, clinical-stage biotechnology company based in San Diego, California. It develops engineered endothelial cell therapies that employ genetically modified human endothelial cells to promote tissue regeneration and restore function in patients with serious medical conditions. The company is pursuing a pipeline of proprietary E-CEL therapies aimed at treating life-threatening hematologic, oncologic, and immunologic diseases, as well as repairing damaged tissues and organs. Through its work, Angiocrine seeks to apply cellular engineering to address complex regenerative needs in medicine. In the market, its target patients are individuals suffering from life-threatening immune and hematologic diseases or tissue and organ injuries where regeneration is needed. A notable development is the Phase 3 registration study AB-205-301 (E-CELERATE) for adults with lymphoma undergoing high-dose chemotherapy and autologous transplantation.